On June 24, 2024, Novo Nordisk A/S announced its share repurchase program started on May 6, 2024, aiming to buy up to DKK 20 billion worth of shares, with nearly DKK 9 billion already spent purchasing 9,884,290 B shares at an average price of DKK 871.10 per share.